Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study

Overview of attention for article published in International Journal of Hematology, January 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 39 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 2,572 followers.

RT @libroazuln: Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study. ht…

15 Jan 2018

Reply Repost Favourite

RT @SaudiLeukemia: Japanese study: ‘Although all the AMLFLT3-ITD patients received HSCT at 1CR, the treatment outcome of AMLFLT3-ITD patien…

14 Jan 2018

Reply Repost Favourite

Japanese study: ‘Although all the AMLFLT3-ITD patients received HSCT at 1CR, the treatment outcome of AMLFLT3-ITD patients did not improve compared with those in a previous study’ https://t.co/nRVd7b6E9A

14 Jan 2018

Reply Repost Favourite

Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study. https://t.co/8ayQqVSOLg

14 Jan 2018

Reply Repost Favourite

Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study. https://t.co/7QWg7suEvl

14 Jan 2018

Reply Repost Favourite